Koyfin Home > Directory > Health Care > Aeglea Biothera > Preferred Equity

Aeglea Biothera Preferred Equity Chart (AGLE)

Aeglea Biothera annual/quarterly Preferred Equity from 2014 to 2016.
  • Aeglea Biothera Preferred Equity for the quarter ending March 03, 2016 was $58m a -0.01% decrease of 0m year over year
  • Aeglea Biothera Preferred Equity for the last 12 months ending March 03, 2016 was $58m a -0.01% decrease of 0m year over year
  • Aeglea Biothera Annual Preferred Equity for 2015 was $58m a 77.11% increase of 45m from 2014
  • Aeglea Biothera Annual Preferred Equity for 2014 was $13m a 66.59% increase of 9m from 2013
  • Aeglea Biothera Annual Preferred Equity for 2013 was $4m
Other Balance Sheet Metrics:
  • Aeglea Biothera Total Assets for the quarter ending September 09, 2018 was $71m a 21.33% increase of 15m year over year
  • Aeglea Biothera Other Liabilities for the quarter ending December 12, 2018 was $0m a -40.28% decrease of 0m year over year
  • Aeglea Biothera Total Equity for the quarter ending September 09, 2018 was $64m a 20.95% increase of 13m year over year
View Chart On Koyfin

Quarterly AGLE Preferred Equity Data

03/2016$58m
12/2015$58m
09/2015$58m
06/2015$58m
03/2015$57m
12/2014$13m
03/2014$4m

Annual AGLE Preferred Equity Data

2015$58m
2014$13m
2013$4m